Fortrea
Braden Saunders is an accomplished executive in business development with extensive experience in the biopharmaceutical and contract research sectors. Currently serving as Executive Director of Business Development at Fortrea since May 2023, Braden has previously held similar roles at Labcorp Drug Development from July 2020 to April 2023 and at Rho for over a decade, where responsibilities included Assistant Vice President and various senior director positions. Earlier career experience includes finance, contracts, and pricing roles at RTI International, Maximus, BAE Systems, and Federal Schedules from August 2001 to January 2007. Braden holds a Bachelor of Science in Management Science, specializing in Production & Operations Management from Virginia Tech's Pamplin College of Business, and completed executive education at Harvard Business School in 2016.
This person is not in any teams
This person is not in any offices
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.